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Abstract
Background: Studies have been conducted to improve the pregnancy rate through the
in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) program. In recent
years, researchers have been focusing on finding impact of high progesterone level on
endometrial receptivity. However, data on whether progesterone level also affects the
quality of the embryo is still limited.
Objective: The aim is to assess the effect of late follicular progesterone level on the
outcome of in vitro fertilization-intracytoplasmic sperm injection (IVF-ICSI).
Materials and Methods: This was a case-control of 245 women who underwent in vitro
fertilization cycle at Halim Fertility Center, Indonesia. The outcomes assessed were
number of oocytes retrieved (OR), maturation rate (MR), fertilization rate (FR), number
of good embryos (GE), number of fair embryos (FE), and number of poor embryos
(PE). The progesterone (P4) and estradiol (E2) levels were analyzed on the day of
human chorionic gonadotropin injection. Serum progesterone level was divided into
three groups: 1. low progesterone (≤ 0.50 ng/ml), 2. normal progesterone (0.51-1.50
ng/ml), and 3. high progesterone (> 1.50 ng/ml). All outcomes were compared amongst
the groups.
Results: Significant differences occurred between progesterone level on the day of
human chorionic gonadotropin administration. The number of OR in group 1, 2, and 3
were 8.41 ± 5.88 vs. 12.99 ± 8.51 vs. 17.58 ± 9.52, respectively.
Conclusion: Progesterone level on the day of human chorionic gonadotropin injection
may have an impact on the outcome of IVF-ICSI.
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fertilization.
How to cite this article: Novia D, Putri Lubis H, Halim B, Pustimbara A, Lestari R, Abinawanto A, Bowolaksono A. “The impact of late follicular progesterone level on





and Natural Sciences of
Universitas Indonesia, Depok,




Received 14 April 2019
Revised 7 September 2019
Accepted 2 December 2019
Production and Hosting by
Knowledge E
Novia et al. This article is
distributed under the terms
of the Creative Commons
Attribution License, which
permits unrestricted use and
redistribution provided that




International Journal of Reproductive BioMedicine Novia et al.
1. Introduction
Infertility can be described as a condition where
married couples fail to conceive clinically after one
year of regular and unprotected sexual intercourse
(1, 2). There are about 8-12% or 50-80 million
couples around the world who experience infertility
(2). Several methods can be used to help infertile
couples conceive. The methods used can be in
the form of drugs such as clomiphene citrate or
procedures such as intrauterine insemination (IUI)
and assisted reproductive technology (ART) such
as in in vitro fertilization (IVF) or in intracytoplasmic
sperm injection (ICSI) (3). About 10% of the infertile
couples need the help of an ART to conceive.
It is known that as much as 40% of infertility is
caused by female factors, 40% by male factors,
and the remaining 20% is caused by both or any
unexplained factors (4).
According to the practice committee of the
American Society for Reproductive Medicine (5),
infertility in female can be caused by a few
factors, such as ovulation disorders where there
are abnormalities in the female’s menstrual cycles,
tubal and pelvic disorders that are caused by
infection and endometriosis, and uterine disorders
that include submucosal myomas, endometrial
polyps, leiomyomas, and Asherman’s syndrome.
Meanwhile, the infertility in male often occurs due
to the poor quality of sperm.
Since the birth of Louise Brown in 1978, many
researches have been conducted to improve the
pregnancy rate through IVF program. In recent
years, researchers have been focusing on finding
the relationship between serum progesterone level
on the day of human chorionic gonadotropin (hCG)
administration and endometrial receptivity or live
birth rate (6-9). Elevated serum progesterone level
on the day of hCG injection is known as premature
luteinization (PL) and is frequently found in GnRH
antagonist cycle. PL on the day of hCG injection
has a negative effect on clinical pregnancy rate
probably due to embryo-endometrial asynchrony
(10).
The assessment of oocyte and embryo quality
based on the progesterone serum levels on the
day of hCG injection has been rarely studied
with a very limited number of cases (7, 11). Some
studies state that there is no association between
progesterone elevation level and fertilization rates
(FRs) as well as the oocyte and embryo quality
(12, 13). However, Huang et al. stated that serum
progesterone concentration on the day of hCG
injection is positively and significantly correlated
with oocyte fertilization failure (9).
Since there are still very few studies on the
effect of progesterone level on oocyte and embryo
quality, hence, this study aims to assess the
effect of late follicular progesterone level on the
outcomes of IVF-ICSI. The outcomes assessed
will be the number of oocytes retrieved (OR),
maturation rate (MR), fertilization rate (FR), number
of good embryos (GE), number of fair embryos (FE),
and number of poor embryos (PE).
2. Materials and Methods
2.1. Study design
A case-control study was conducted among
infertile couples who underwent IVF-ICSI cycle at
the Halim Fertility Center, Stella Maris Women
and Children Hospital, Indonesia, from January to
August 2018. The inclusion criteria in this study
were all infertile couples who underwent IVF-ICSI
at the center, and the exclusion criteria was women
who did not check progesterone and estradiol
serum at the time of hCG injection. A total of 245
infertile women who underwent IVF cycle during
the period in which serum P4 level was measured
on the day of hCG injection were included in the
study. The outcomes assessedwere number of OR,
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MR, FR, GE, FE, and PE. The embryo quality was
measured based on Istanbul consensus, ALPHA
Scientist in Reproductive Medicine & ESHRE
Special Interest Group Embryology (14).
2.2. Ovarian hyperstimulation
controlled
The standard protocol for controlled ovarian
stimulation was carried out by administering a
recombinant follicle-stimulating hormone (FSH)
(Gonal-F; Serono; Switzerland) at a dose of 150-300
IU. This protocol used on day 2 in the menstrual
cycle. When at least one follicle had reached >14
mm, a gonadotropin-releasing hormone (GnRH)
antagonist, Cetrotide (Serono; Switzerland), was
used to prevent a premature luteinizing hormone
(LH) surge at 0.25 mg dose. The follicular growth
was monitored by transvaginal ultrasound since
day 4 of the gonadotropin injection, with the
average of stimulation duration was 8-10 days.
A recombinant hCG (Ovidrel; Serono; Switzerland)
was administered to trigger oocyte maturation
when three lead follicles had reached 17-18 mm,
at least. Oocytes were then retrieved 35-36 hr
after hCG injection using an ultrasound-guided
transvaginal needle aspiration of follicles.
2.3. Oocyte morphology assessment
and ICSI procedure
Cumulus-oocyte complexes (COC) retrieved
were washed in MOPS-buffered medium with
human serum albumin (GMOPS Plus; Vitrolife;
Sweden). The COC were cultured in 0.8 ml GIVF
medium (Vitrolife; Sweden) under paraffin oil at
37°C, 6% CO2 and 5% O2 for 2 hr after retrieval.
After 2 hr of incubation, COCwere then exposed to
hyaluronidase (80 IU Synvitro Hyadase; Medicult;
Denmark) in order to remove the cumulus cells.
Metaphase II oocytes were inseminated using the
ICSI method 38-42 hr after the hCG injection. Prior
to ICSI, each oocyte was set into a 15 μl droplet of
GMOPS Plus (Vitrolife; Sweden) under paraffin oil
(Ovoil; Vitrolife; Sweden). Injected oocytes were
cultured in a single droplet of 50 μl GTL (Vitrolife;
Sweden) until 3 days.
On the day of oocyte(s) retrieval, spouse
collected the sperm samples using masturbation
method. The semen samples were analyzed for
concentration, motility, as well as morphology. The
semen was processed and selected by using a
density gradient method, layer concentration used
was 45:90% SpermGrad (Vitrolife; Sweden). The
solution was centrifuged at 300-600 g for 10-
20 min and re-suspended with 1 ml of MOPS-
buffered medium (GMOPS Plus, Vitrolife; Sweden).
For ICSI purposes, a single spermatozoon was
immobilized using a polyvinylpyrrolidone (PVP)
solution (Medicult; Denmark).
2.4. Embryo morphology assessment
Embryo fertilization was appraised 17 ± 1
hr after the ICSI with the presence of two
pronuclei and second polar bodies. Day 3
embryo quality check was assessed 68 ± 1 hr
after the ICSI. Embryo quality was assessed
morphologically by considering the number
of blastomeres, degree of fragmentation,
cell size, and presence of multinucleation.
Embryo morphology was then classified as
good, fair, and poor. Embryos with six to eight
equally sized mononucleotide blastomeres
and fragmentation < 10% were scored as
good. Those with six to eight unequally sized
mononucleotide blastomeres and fragmentation
between 10-25% were scored as fair. Embryos
with severe fragmentation (> 25%), unequal size of
blastomeres, and with multinucleation were scored
as poor.
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2.5. Hormones measurements
Blood sampling was done in the morning of
the day of hCG injection for the measurement
of progesterone and estradiol level. The serum
progesterone and estradiol were analyzed using
a microparticle enzyme immunoassay (Vidas;
bioMérieux SA) system. The progesterone level
was then divided into three groups: group 1
with low progesterone (≤ 0.50 ng/ml), group
2 with normal progesterone (0.51-1.50 ng/ml),
and group 3 with high progesterone (> 1.50
ng/ml). All outcomes were compared amongst
groups.
2.6. Ethical consideration
Each couple which enrolled in the
study signed a written informed consent.
The study was authorized by the Ethics




We tabulated data on subjects’ age and Body
Mass Index (BMI) as demographics of subjects.
Oocyte retrieved, maturation rate, and embryo
quality were tabulated as treatment protocol
and outcomes. Estradiol level was tabulated
as endocrine profile. Data were analyzed
statistically using a Wilcoxon test. Results were
then expressed as mean ± SD. A p-value of <
0.05 was considered to be statistically significant.
Data were analyzed using software IBM SPSS
Statistics (Version 25) for the data analysis
process.
3. Results
A total of 245 women underwent in vitro
fertilization cycle at the Halim Fertility Center,
Stella Maris Women and Children Hospital,
Indonesia, from January to August 2018. All
subjects were then divided into three groups
based on their serum progesterone level analyzed
in the morning of the day of hCG injection: group
1 with low progesterone (≤ 0.50 ng/ml), group
2 with normal progesterone (0.51-1.50 ng/ml),
and group 3 with high progesterone (> 1.50
ng/ml).
As shown in Table I, the subjects that mainly
belonged to group 2 had a higher cycles numbers
compared to other groups (n = 117). The age range
of subjects were 22-47 yr and the mean age is
as shown in Table I. The mean body mass index
of the three groups was 25.26 ± 3.88 kg/m2;
25.00 ± 3.72 kg/m2; and 24.40 ± 3.51 kg/m2,
respectively.
As shown in Table II, the number of OR was
significantly higher in group 3 compared to
the other groups. It also shows that oocytes in
group 1 had a significantly higher maturation
and FRs (75.78%; 76.12%, respectively; p =
0.001) but had the lowest percent of GE (p
= 0.009). Group 2 had the highest percent
of FE and also the lowest FR (p = 0.001).
Although group 3 had the lowest maturation
rate compared to the other groups, it had a
significantly higher percent of GE. Apart from
the low maturation rate and the high percent of
GE, group 3 also had the highest percent of PE
compared to the other groups although it was
not significant (p = 0.205). The estradiol serum
level on the day of hCG injection was 1247.09
± 730.56, 2092.39 ± 1276.42, and 3266.43
± 319.06 in group 1, 2, and 3, respectively
where the highest level is in group 3 (p =
0.001).
Page 370 https://doi.org/10.18502/ijrm.v13i5.7157
International Journal of Reproductive BioMedicine Progesterone impacts in vitro fertilization-intracytoplasmic sperm injection outcome
Table I. Demographics of the subjects
Group 1 Group 2 Group 3
Cycles (n) 64 117 64
Age (yr) 35.27 ± 4.85 33.32 ± 4.60 32.31 ± 4.21
BMI (kg/m2) 25.26 ± 3.88 25.00 ± 3.72 24.40 ± 3.51
*BMI: Body mass index
Table II. Treatment protocol and outcomes
Total Group 1 Group 2 Group 3 P-value
Oocyte retrieved* 12.99 ± 8.82 8.41 ± 5.88 12.99 ± 8.51 17.58 ± 9.52 0.001
Maturation rate** 72.86 75.78 72.44 70.71 0.001
Fertilization rate** 72.25 76.12 70.69 71.21 0.001
Good embryo** 23.09 21.33 20.36 29.01 0.009
Fair embryo** 51.53 59.11 52.74 43.68 0.001
Poor embryo** 25.37 19.56 26.88 27.30 0.205
*Data presented as Mean ± SD. Wilcoxon test, **Data presented as percentages
4. Discussion
Our result suggests that progesterone level
on the day of human chorionic gonadotropin
injection may have an impact on the outcome
of in vitro fertilization IVF-ICSI. Oocytes are not
able to express gonadotropin to induce their
own maturation. Hence, LH is responsible in
activating theca cells and granulosa cells so
that oocytes can return to the meiotic stage
and begin the maturation process (15). Human
chorionic gonadotropin (hCG) is a homologue of
LH which can activate LH receptors, a primary,
and also the most commonly used, trigger for
oocyte maturation (16). In IVF, hCG is a hormone
used to create an expression for LH-like exposure.
The influence of serum progesterone level on
the day of hCG injection on the outcome of
the IVF program has long been a matter of
debate.
In this study, we found a significant difference
in the serum progesterone level with regards to
oocyte maturation and FRs among the groups.
This result is in line with a recent study which
stated that serum progesterone concentration
on the day of hCG injection was positively
and significantly correlated with the rescue
ICSI rate (9). A high progesterone level (>
1.50 ng/ml) on the day of hCG injection may
have negatively affected oocyte fertilization,
which indicates that greater attention will
be needed to avoid fertilization failure. Some
studies have reported that an elevation of serum
progesterone level as a result of premature
oocyte maturation or aging may reduce FR.
This oocyte aging may lead to disorganization
of the oocyte spindle and cytoplasm as well
as the retention of the second polar body
which may result in chromosomal anomalies
(9).
Our study also showed that high level of
progesterone on the day of hCG injection did
not have an adverse effect on embryo quality.
As shown in Figure 1, embryo in group 3 can
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also develop into a good-quality embryo. In
contrast, however, some study showed that
high progesterone level may have detrimental
effects on oocyte and embryo quality (17, 18).
Sonigo et al. (13) stated that embryo cleavage
and blastocyst rate are not affected by the
elevated progesterone level. Slight impact of
the elevated progesterone level on oocyte
or embryo quality is found consistent with
the evidence that female gametes do not
express progesterone receptor. Previous
study showed that the quality of embryo is
mostly determined by the quality of oocytes,
which include the first polar body, meiotic
spindle, cumulus cells, and mitochondria
(19).
Women who are high responders of
gonadotropin, with > 10 follicles in the size
of > 14 mm and estradiol level of > 2500
pg/ml on the day of hCG injection may also
have a significantly high rise of progesterone.
Serum progesterone level on the day of hCG
injection reported closely related to the dose
of gonadotropin injected irrespectively to the
type given. Some study also explained that this
event is able to occur due to the initial intense
recombinant FSH dose administered during the
first six days of stimulation, which in return, may
increase the steroidogenetic activity of granulosa
cell. According to the study conducted by MERiT,
the rise of serum progesterone appears to be
more often in the FSH recombinant treatment
group compared to the HMG treatment group (10,
20).
PL may negatively impact the success rate of
IVF/ICSI fresh transfer, not through an ovarian
event but its influence on the endometrium,
which may possibly lead to impaired endometrial
receptivity. Elevated progesterone level may cause
embryo/endometrial asynchrony, which in return
may reduce the probability of implantation (21).
Hence, clinicians will need to make use of some
strategies in controlling PL with the aim of avoiding
its possible deleterious effects in fresh IVF cycles.
One of the strategies to improve the pregnancy
rate in PL cases is to cancel the fresh ET and
replacing the fresh embryo with frozen-thawed
embryo (22).
The limitation in this study is related to the
number of samples. Due to the short duration
of the study, we only involved 245 women.
Since there are some points in the study
that are still being debated, hence, further
research with a longer duration is needed to
improve the result of this study, which allows the
researcher to recruit more samples. For further
research, we would like to suggest a study to
assess the association between progesterone
receptor polymorphism and the outcome of
IVF.
Figure 1. Embryomorphology assessment in Group 3. (a) Fertilization results in the presence of two pronuclei in oocyte and second
polar bodies seen in perivitelline space. (b) The good embryo has blastomeres of equal size with no fragmentation. (c) Fair embryo
has unequal sized blastomeres and fragmentation between 10 and 25%. (d) The poor embryo has a severe fragmentation and
unequal sized blastomere.(×400 magnification).
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5. Conclusion
Increased progesterone level on the day of
follicle maturation may not affect embryo quality
but may have an adverse effect on oocyte
maturation and FRs. Elevated estradiol and
progesterone level on the day of hCG injection
were the effects of the increasing number and size
of follicles.
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